Therapy Area
Showing 91–100 of 124 resultsSorted by latest
-
Therapy Area
Crohn’s Disease (CD) Therapeutics Market Analysis and Forecast by Medication Class, Distribution Channel, and Geography Through 2035
Expected Market Expansion through Advanced Treatment Options, Increased Awareness, and Strategic Alliances to Expand Pipeline and Drive Demand
-
Therapy Area
Analysis and Outlook for the Chimeric Antigen Receptor (CAR) T-Cell Treatment Sector by Category, Indication, Demographics, and Geography Through 2035
Advancements in Bispecific Therapies Augment Treatment Precision, Enhancing Clinical Results and Diminishing Unwanted Reactions.
-
Therapy Area
Comprehensive Analysis of the Hepatic Encephalopathy Treatment Market: Trends, Segmentation, and Forecasts to 2035
Leveraging Artificial Intelligence for Enhanced Diagnostics and Optimized Management of Liver-Related Brain Dysfunction
-
Therapy Area
Focal Segmental Glomerulosclerosis (FSGS) Treatment Market: Analysis and Forecast by Disease Subtype, Medication Category, Therapeutic Modality, and Geographic Region Through 2035
Growth in the focal segmental glomerulosclerosis therapeutics market is anticipated across emerging economies in the Asia-Pacific region, propelled by increased disease incidence and expanded government-funded healthcare programs.
-
Therapy Area
Comprehensive Evaluation of the Market for Strep Throat Treatments: Size, Share, and Forecast from 2025 to 2035
Analysis of the Strep Throat Treatment Market, Segmented by Diagnostic Method, Healthcare Provider, and Geographic Region, Covering the Years 2025 to 2035.
-
Therapy Area
Neovascular Age-Related Macular Degeneration (AMD) Treatment Market: Analysis and Forecast by Drug Class, Disease Subtype, Patient Demographics, Distribution Channel, and Region to 2035
Increased Focus on Ophthalmic Research to Spur Advances in Targeted Therapies, Enhancing Efficacy and Minimizing Adverse Effects.
-
Therapy Area
Lupus Nephritis Therapeutics Market: Assessment of Trends, Segmentation by Drug Type, Delivery Method, Distribution, and Regional Forecasts Through 2035
Enhanced Affordability Through Increased Biosimilar Availability for Autoimmune Disease Biologics Will Positively Influence Pricing and Treatment Accessibility.
-
Therapy Area
Severe Hypertriglyceridemia (SHTG) Therapeutics: Market Forecast, Trend Analysis, and Treatment Innovations to 2035
Exploring Advanced Strategies in Lipid Disorder Management: New Horizons in Severe Hypertriglyceridemia (SHTG) Therapies.
-
Therapy Area
Oncology Adjuvants Market Analysis by Application, Indication, and Intended User from 2025 to 2035
Elevated Cancer Incidence and Progress in Immunological Treatments Promoting the Oncology Adjuvants Sector.
-
Therapy Area
Adrenal Insufficiency Crisis Management: Market Examination and Projections by Diagnostic Approach, Therapeutic Intervention, Distribution Network, and Geographic Region, Through 2035
Advancements in Therapies and Growing Public Knowledge Propel the Market for Adrenal Crisis Interventions
